Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 51, 2021 - Issue 22
315
Views
15
CrossRef citations to date
0
Altmetric
Articles

Synthesis and biological activity on IBD virus of diverse heterocyclic systems derived from 2-cyano-N'-((2-oxo-1,2-dihydroquinolin-3-yl)methylene)acetohydrazide

, , , , , ORCID Icon & ORCID Icon show all
Pages 3366-3378 | Received 15 Jul 2021, Published online: 26 Aug 2021
 

Abstract

A 2-cyano-N'-((2-oxo-1,2-dihydroquinolin-3-yl)methylene)ethanohydrazide (3) was synthesized in 87% yield via condensation of 3-formyl-2-oxoquinoline (1) with 2-cyanoethanohydrazide (2). The titled compound was then treated with some electrophilic reagents to construct some novel quinoline-based heterocyclic systems, for example, pyrazole, thiazoline, pyridine, pyrimidine, chromene, and thiophene derivatives. The behavior of the titled compound toward hydrazine and phenylhydrazine was examined. Seven substances were screened for their in vitro antiviral activity against infectious bursal disease virus (IBDV) in specific pathogen-free (SPF) chicken embryos and evaluation of immune-boosting properties of these substances in SPF chicks. The antiviral results disclosed that compounds 5a and 17 exhibited the most potency as compared to the reference drug, ribavirin. Therefore, they are considered as promising antiviral additives in vaccine production of IBVD vaccine to increase the immune stimulant.

Graphical Abstract

Disclosure statement

The authors declare no conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.